【结 构 式】 |
【分子编号】32138 【品名】Sarcosine ethyl ester; Ethyl 2-(methylamino)acetate 【CA登记号】52605-49-9 |
【 分 子 式 】C5H11NO2 【 分 子 量 】117.14788 【元素组成】C 51.26% H 9.46% N 11.96% O 27.31% |
合成路线1
该中间体在本合成路线中的序号:(VI)The reaction of methyl 3-hydroxythiophene-2-carboxylate (I) with PCl5 in refluxing CCl4 gives 3-chlorothiophene-2-carboxylic acid (II), which by treatment with NaHSO3 and Cu in basic water at 143 C in a pressure vessel is converted into 3-sulfothiophene-2-carboxylic acid (III). The esterification of (III) with refluxing methanol affords methyl 3-sulfothiophene-2-carboxylate (IV), which by reaction with refluxing SOCl2 yields methyl-3-chlorosulfonylthiophene-2-carboxylate (V). The condensation of (V) with sarcosine ethyl ester (VI) in hot CHCl3 gives methyl-3-(N-ethoxycarbonyl-methyl-N-methylsulfamoyl)thiophene-2-carboxylate (VII), which is cyclized by treatment with sodium methoxide in refluxing methanol affording 3-ethoxycarbonyl-4-hydroxy-2-methyl-2H-thieno-[2,3-e]-1,2-thiazine-1,1-dioxide (VIII). Finally, this compound is condensed with 2-aminopyridine (IX) in refluxing toluene.
【1】 Horomatka, O.; Binder, D.; Pfister, R.; Zeller, P. (F. Hoffmann-La Roche AG); Thienothaiazine derivatives. DE 2537070; FR 2303803; JP 51048694; NL 7510057 . |
【2】 Serradell, M.N.; Blancafort, P.; Castaner, J.; Tenoxicam. Drugs Fut 1982, 7, 7, 493. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 32134 | Methyl 3-hydroxy-2-thiophenecarboxylate | C6H6O3S | 详情 | 详情 | |
(II) | 32135 | 3-Chloro-2-thiophenecarboxylic acid | 59337-89-2 | C5H3ClO2S | 详情 | 详情 |
(III) | 32136 | 3-Sulfothiophene-2-carboxylic acid; 3-Sulfo-2-thiophenecarboxylic acid | C5H4O5S2 | 详情 | 详情 | |
(IV) | 32137 | Methyl 3-sulfothiophene-2-carboxylate; 2-(Methoxycarbonyl)-3-thiophenesulfonic acid | C6H6O5S2 | 详情 | 详情 | |
(V) | 17836 | Methyl 3-(chlorosulfonyl)-2-thiophenecarboxylate; Methyl-3-chlorosulfonylthiophene-2-carboxylate | C6H5ClO4S2 | 详情 | 详情 | |
(VI) | 32138 | Sarcosine ethyl ester; Ethyl 2-(methylamino)acetate | 52605-49-9 | C5H11NO2 | 详情 | 详情 |
(VII) | 32139 | Methyl-3-(N-ethoxycarbonyl-methyl-N-methylsulfamoyl)thiophene-2-carboxylate; Methyl 3-[[(2-ethoxy-2-oxoethyl)(methyl)amino]sulfonyl]-2-thiophenecarboxylate | C11H15NO6S2 | 详情 | 详情 | |
(VIII) | 32140 | Ethyl 4-hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate; 3-Ethoxycarbonyl-4-hydroxy-2-methyl-2H-thieno-[2,3-e]-1,2-thiazine-1,1-dioxide | C10H11NO5S2 | 详情 | 详情 | |
(IX) | 11305 | 2-Pyridinamine; 2-Pyridinylamine; 2-Aminopyridine | 504-29-0 | C5H6N2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(XXII)The tripeptide building block (XXVII) is prepared as follows. Cyclization of N-Boc-L-serine (XIX) to the beta-lactone (XX) is achieved by treatment with DEAD and PPh3. Subsequent ring opening with diphenyldiselenide in the presence of a reducing agent leads to selenide (XXI). Aminoacid (XXI) is then coupled to sarcosine ethyl ester (XXII) to afford dipeptide (XXIII). After acidic Boc group cleavage in (XXIII), the resultant carboxylic acid (XXIV) is coupled to N-Boc-D-aminobutyric acid (XXV) to give (XXVI). The N-Boc group of (XXVI) is then deprotected with trifluoroacetic acid, producing intermediate (XXVII).
【1】 Ley, S.V.; et al.; Total synthesis of the cyclic heptapeptide argyrin B: A new potent inhibitor of T-cell independent antibody formation. Org Lett 2002, 4, 5, 711. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XIX) | 20126 | (2S)-2-[(tert-butoxycarbonyl)amino]-3-hydroxypropionic acid | C8H15NO5 | 详情 | 详情 | |
(XX) | 58838 | tert-butyl (3S)-2-oxooxetanylcarbamate | C8H13NO4 | 详情 | 详情 | |
(XXI) | 58839 | (2R)-2-[(tert-butoxycarbonyl)amino]-3-(phenylselanyl)propanoic acid | C14H19NO4Se | 详情 | 详情 | |
(XXII) | 32138 | Sarcosine ethyl ester; Ethyl 2-(methylamino)acetate | 52605-49-9 | C5H11NO2 | 详情 | 详情 |
(XXIII) | 58840 | ethyl 2-[[(2R)-2-[(tert-butoxycarbonyl)amino]-3-(phenylselanyl)propanoyl](methyl)amino]acetate | C19H28N2O5Se | 详情 | 详情 | |
(XXIV) | 58841 | ethyl 2-[[(2R)-2-amino-3-(phenylselanyl)propanoyl](methyl)amino]acetate | C14H20N2O3Se | 详情 | 详情 | |
(XXV) | 58842 | (2R)-2-[(tert-butoxycarbonyl)amino]butanoic acid | C9H17NO4 | 详情 | 详情 | |
(XXVI) | 58843 | ethyl (6R,9R)-6-ethyl-2,2,11-trimethyl-4,7,10-trioxo-9-[(phenylselanyl)methyl]-3-oxa-5,8,11-triazatridecan-13-oate | C23H35N3O6Se | 详情 | 详情 | |
(XXVII) | 58844 | ethyl 2-[[(2R)-2-{[(2R)-2-aminobutanoyl]amino}-3-(phenylselanyl)propanoyl](methyl)amino]acetate | C18H27N3O4Se | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(IV)
【1】 Sajja E, Vetukuri VR, Ningam SR, et aL. 2007. Process for producing tadalafiL. W0 2007100387 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(III) | 66758 | methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate hydrochloride | C20H18N2O4.HCl | 详情 | 详情 | |
(I) | 20416 | methyl (2R)-2-amino-3-(1H-indol-3-yl)propanoate | C12H14N2O2 | 详情 | 详情 | |
(II) | 10127 | 1,3-Benzodioxole-5-carbaldehyde; Heliotropine | 120-57-0 | C8H6O3 | 详情 | 详情 |
(IV) | 32138 | Sarcosine ethyl ester; Ethyl 2-(methylamino)acetate | 52605-49-9 | C5H11NO2 | 详情 | 详情 |